Core Laboratories Inc.

Valuation Analysis

About the Company

Core Laboratories Inc. en bref

Core Laboratories Inc. (CLB) is currently trading at 10,20 € with a market capitalization of 470 M €. The trailing P/E ratio stands at 19.16x, with a forward P/E of 13.67x. The 52-week range spans from 8,48 € to 17,77 €; the current price is 42.6% below the yearly high. Year-over-year revenue growth stands at -1.4%. The net profit margin stands at 5.53%.

💰 Dividende

Core Laboratories Inc. pays an annual dividend of 0,03 € per share, representing a yield of 0.34%. The payout ratio stands at 6.56%.

📊 Avis des analystes

3 analystes évaluent Core Laboratories Inc. (CLB) au consensus : None. L'objectif de cours moyen est de 14,25 €, soit un potentiel de +39.72% par rapport au cours actuel. La fourchette des objectifs de cours des analystes va de 10,47 € à 19,20 €.

Core Laboratories Inc. : la thèse d'investissement en détail

Core Laboratories Inc. (CLB) operates in the Energy — specifically Oil & Gas Equipment & Services — and is headquartered in United States. Below is a structured read of the investment case built directly from the latest fundamentals, valuation multiples, analyst positioning and smart-money flows. Each section translates raw numbers into the investment logic they imply, so you can decide whether the risk/reward fits your portfolio.

Le scénario baissier

Revenue is contracting at -1.4% year-over-year — until that trend reverses, valuation is exposed to further downgrades. Short interest sits at 29.5% of float — a meaningful contingent of professionals is positioned for the share to fall, which deserves attention even if their thesis may turn out to be wrong.

Valorisation en contexte

The PEG ratio at 1.44 sits in the reasonable zone — the price tag is roughly aligned with the company's growth profile, neither punishing nor euphoric.

À surveiller

• The forward P/E of 13.67x is meaningfully below the trailing 19.16x — analysts expect earnings to step up; the next earnings release is the test.
• The price sits in the lower quartile of the 52-week range — value hunters often start scaling in around this zone if fundamentals hold.
• The analyst consensus price target implies 39.72% upside — if the next two quarters confirm the underlying thesis, target hikes typically follow.

Thèse d'investissement : forces et faiblesses

Aperçu technique

Price is below both the 50- and 200-day moving averages, with 50d below 200d — a bearish picture (death-cross alignment).

Profil de risque

The data points to relatively defensive market behavior, elevated short interest (29.5%).

Trading Data

💵 Dividend Info

Related Stocks in the Same Sector

Where can I buy Core Laboratories Inc.?

Compare top-rated brokers — low fees, trusted providers, fully regulated.